整合多模态超声与临床特征预测病理性瘢痕³²P敷贴近距离放疗反应
本研究回顾性纳入48例病理性瘢痕患者共169个病灶,构建并内部验证整合超声特征与临床特征的预测模型,用于评估³²P敷贴近距离放疗疗效。瘢痕厚度、血管指数、病程和平均剪切波速度被确定为独立预测因素,训练集AUC为0.969,验证集AUC为0.790,模型校准良好。
要点
- 瘢痕厚度、血管指数、病程和平均剪切波速度为³²P敷贴疗效的独立预测因素。
- 预测模型训练集AUC为0.969,内部验证集AUC为0.790。
- 模型校准曲线显示预测与实际结局一致性良好。
核心结论
- 整合瘢痕厚度、血管指数、病程和平均剪切波速度的多变量回归模型可可靠预测病理性瘢痕³²P敷贴近距离放疗疗效,有助于优化治疗策略并降低放疗相关风险。
研究设计与样本
- 回顾性分析48例病理性瘢痕患者共169个病灶,按约7:3随机分为训练集119个病灶和内部验证集50个病灶。
主要发现
- 瘢痕厚度、血管指数、病程和平均剪切波速度均为疗效的独立预测因素(均P < 0.05)。
- 训练集AUC为0.969(95% CI:0.944-0.994),验证集AUC为0.790(95% CI:0.664-0.916)。
- 校准曲线显示预测与观察结局一致性良好(χ² = 3.598,P = 0.891)。
关键数值与推荐
- 预测模型纳入瘢痕厚度、血管指数、病程和平均剪切波速度四个变量。
临床怎么用
- 该模型可用于接受³²P敷贴近距离放疗的病理性瘢痕患者,辅助筛选可能获益人群并优化治疗决策。
局限性
- 本研究为单中心回顾性分析,样本量较小(48例患者、169个病灶),仅进行内部验证,需外部验证确认泛化能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and validate a predictive model integrating ultrasound features and clinical characteristics for assessing the efficacy of ³²P patch brachytherapy in pathological scars. METHODS: A total of 48 patients with pathological scars (yielding 169 total lesions) who received ³²P patch brachytherapy at the Department of Nuclear Medicine, the Second Affiliated Hospital of Anhui Medical University (April 1, 2023 - December 31, 2025) were retrospectively analyzed. The patients were randomly divided into a training set and an internal validation set at an approximate 7:3 ratio, yielding 119 and 50 lesions, respectively. Lesions in each set were further divided into an effective group and an ineffective group based on the therapeutic response. Univariate mixed-effects logistic regression analysis was employed to compare ultrasound and clinical characteristics between the two groups. Variables with statistical significance were entered into a multivariate mixed-effects logistic regression analysis to identify independent predictors of treatment efficacy and to construct a predictive model. The discriminative performance of the model was internally validated using the validation set. RESULTS: Scar thickness, vascular index (VI), disease duration, and mean shear wave velocity (SWV) were identified as independent predictors of the efficacy of ³²P patch brachytherapy in pathological scars (all P < 0.05). The predictive model demonstrated an area under the ROC curve (AUC) of 0.969 (95% CI: 0.944-0.994) in the training set. The calibration curve indicated good agreement between predicted and observed outcomes (χ² = 3.598, P = 0.891). Internal validation in the validation set yielded an AUC of 0.790(95% CI: 0.664-0.916). CONCLUSION: A multivariable regression model incorporating scar thickness, VI, disease duration, and mean SWV provides a reliable tool for predicting the efficacy of ³²P patch brachytherapy for pathological scars. This model may assist in optimizing clinical treatment strategies and reducing potential short- and long-term risks associated with radiotherapy.
引用
- Cao LL, Bi Y, Zhang G, et al. Predicting response to ³²P patch brachytherapy in pathological scars: A model integrating multimodal ultrasound and clinical features. Burns. 2026. PMID: 42868687. doi:10.1016/j.burns.2026.108224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。